Toward a treatment for thyroid hormone transporter MCT8 deficiency – achievements and challenges
Open Access
- 1 November 2024
- journal article
- review article
- Published by Bioscientifica in European Thyroid Journal
- Vol. 13 (6)
Abstract
Patients with an inactive thyroid hormone (TH) transporter MCT8 (Allan–Herndon–Dudley Syndrome, AHDS) display severe neurological impairments and motor disabilities, indicating an indispensable function of MCT8 in facilitating TH access to the human brain. Consequently, the CNS of AHDS patients appears to be in a TH deficient state, which greatly compromises proper neural development and function. Another hallmark of this disease is that patients exhibit elevated serum T3 levels, leading to a hyperthyroid situation in peripheral tissues. Several treatment strategies have been developed and evaluated in preclinical mouse models as well as in patients. Here, we discuss these different therapeutic approaches to overcome MCT8 deficiency and summarize the current achievements and challenges in improving brain maturation in the absence of MCT8.Keywords
This publication has 67 references indexed in Scilit:
- Expression of the Thyroid Hormone Transporters Monocarboxylate Transporter-8 (SLC16A2) and Organic Ion Transporter-14 (SLCO1C1) at the Blood-Brain BarrierEndocrinology, 2008
- Beneficial Effects of Propylthiouracil plusl-Thyroxine Treatment in a Patient with a Mutation inMCT8The Journal of Clinical Endocrinology & Metabolism, 2008
- Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8Journal of Clinical Investigation, 2007
- Tissue-Specific Thyroid Hormone Deprivation and Excess in Monocarboxylate Transporter (Mct) 8-Deficient MiceEndocrinology, 2006
- Allan-Herndon-Dudley Syndrome and the Monocarboxylate Transporter 8 (MCT8) GeneThe American Journal of Human Genetics, 2005
- Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardationThe Lancet, 2004
- Involvement of Multispecific Organic Anion Transporter, Oatp14 (Slc21a14), in the Transport of Thyroxine across the Blood-Brain BarrierEndocrinology, 2004
- A Novel Syndrome Combining Thyroid and Neurological Abnormalities Is Associated with Mutations in a Monocarboxylate Transporter GeneThe American Journal of Human Genetics, 2004
- Identification of a Novel Human Organic Anion Transporting Polypeptide as a High Affinity Thyroxine TransporterMolecular Endocrinology, 2002
- Plasma Membrane Transport of Thyroid Hormones and Its Role in Thyroid Hormone Metabolism and BioavailabilityEndocrine Reviews, 2001